147 related articles for article (PubMed ID: 21940410)
21. Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice.
Monteyne P; Coutelier JP
J Gen Virol; 1994 May; 75 ( Pt 5)():1173-6. PubMed ID: 8176379
[TBL] [Abstract][Full Text] [Related]
22. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids.
Schröder NW; Opitz B; Lamping N; Michelsen KS; Zähringer U; Göbel UB; Schumann RR
J Immunol; 2000 Sep; 165(5):2683-93. PubMed ID: 10946299
[TBL] [Abstract][Full Text] [Related]
23. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus.
Plagemann PG
Virology; 2001 Nov; 290(1):11-20. PubMed ID: 11882995
[TBL] [Abstract][Full Text] [Related]
24. The IA antigen is not the major receptor for lactate dehydrogenase-elevating virus on macrophages from CBA and BALB/c mice.
Buxton IK; Chan SP; Plagemann PG
Virus Res; 1988 Feb; 9(2-3):205-19. PubMed ID: 3162628
[TBL] [Abstract][Full Text] [Related]
25. Natural killer cell activation after infection with lactate dehydrogenase-elevating virus.
Markine-Goriaynoff D; Hulhoven X; Cambiaso CL; Monteyne P; Briet T; Gonzalez MD; Coulie P; Coutelier JP
J Gen Virol; 2002 Nov; 83(Pt 11):2709-2716. PubMed ID: 12388806
[TBL] [Abstract][Full Text] [Related]
26. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection.
Chen Z; Rowland RR; Anderson GW; Palmer GA; Plagemann PG
J Virol; 1997 Apr; 71(4):2913-20. PubMed ID: 9060649
[TBL] [Abstract][Full Text] [Related]
27. Multiplex fluorescent immunoassay for detection of mice infected with lactate dehydrogenase elevating virus.
Adams V; Myles MH
J Am Assoc Lab Anim Sci; 2013; 52(3):253-8. PubMed ID: 23849407
[TBL] [Abstract][Full Text] [Related]
28. Lactic dehydrogenase virus (LDV) infection inhibits allergic eosinophil reaction in the airway.
Morimoto M; Ohji T; Iwata H; Hayashi T
Res Vet Sci; 2002 Apr; 72(2):131-6. PubMed ID: 12027593
[TBL] [Abstract][Full Text] [Related]
29. Extensive cytocidal replication of lactate dehydrogenase-elevating virus in cultured peritoneal macrophages from 1-2-week-old mice.
Onyekaba CO; Harty JT; Plagemann PG
Virus Res; 1989 Dec; 14(4):327-38. PubMed ID: 2623946
[TBL] [Abstract][Full Text] [Related]
30. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.
Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Heumann D
J Immunol; 2001 Sep; 167(6):3329-38. PubMed ID: 11544322
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 production by macrophages from BALB/c mice with a chronic infection of lactic dehydrogenase virus.
Iwata H; Hayashi T
Jikken Dobutsu; 1994 Oct; 43(4):559-62. PubMed ID: 7805801
[TBL] [Abstract][Full Text] [Related]
32. Changes in the specificity of antibodies in mice infected with lactate dehydrogenase-elevating virus.
Gómez KA; Coutelier JP; Retegui LA
Scand J Immunol; 1997 Aug; 46(2):168-74. PubMed ID: 9583997
[TBL] [Abstract][Full Text] [Related]
33. Acute infection of mice with lactate dehydrogenase-elevating virus enhances Fc and complement receptor activity of peritoneal macrophages.
Lussenhop N; Holmes B; Cafruny WA; Plagemann PG
J Gen Virol; 1982 Jul; 61 (Pt l)():25-32. PubMed ID: 7119750
[TBL] [Abstract][Full Text] [Related]
34. Decrease in neutrophil migration induced by endotoxin and suppression of interleukin-1 production by macrophages in lactic dehydrogenase virus-infected mice.
Hayashi T; Iwata H; Hasegawa T; Ozaki M; Yamamoto H; Onodera T
J Comp Pathol; 1991 Feb; 104(2):161-70. PubMed ID: 1650801
[TBL] [Abstract][Full Text] [Related]
35. The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane.
Tanimura N; Saitoh S; Ohto U; Akashi-Takamura S; Fujimoto Y; Fukase K; Shimizu T; Miyake K
Int Immunol; 2014 Jun; 26(6):307-14. PubMed ID: 24380872
[TBL] [Abstract][Full Text] [Related]
36. Pseudotype virions formed between mouse hepatitis virus and lactate dehydrogenase-elevating virus (LDV) mediate LDV replication in cells resistant to infection by LDV virions.
Even C; Plagemann PG
J Virol; 1995 Jul; 69(7):4237-44. PubMed ID: 7769683
[TBL] [Abstract][Full Text] [Related]
37. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
Weiland E; Weiland F; Grossmann A
J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
[TBL] [Abstract][Full Text] [Related]
38. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).
Viladés C; Escoté X; López-Dupla M; Martinez E; Domingo P; Asensi V; Leal M; Peraire J; Inza MI; Arnedo M; Gutiérrez M; Valle-Garay E; Ferrando-Martinez S; Olona M; Alba V; Sirvent JJ; Gatell JM; Vidal F;
J Antimicrob Chemother; 2014 Jun; 69(6):1653-9. PubMed ID: 24535275
[TBL] [Abstract][Full Text] [Related]
39. Lactic dehydrogenase virus inhibits allergic immunoglobulin E production: in vivo molecular analysis of cytokines.
Morimoto M; Iwata H; Hayashi T
Scand J Immunol; 1999 Aug; 50(2):211-4. PubMed ID: 10447927
[TBL] [Abstract][Full Text] [Related]
40. Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus.
Inada T; Mims CA
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1469-77. PubMed ID: 3860626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]